The Chief Executive of the China Spinal Cord Injury Network (CSCIN), Dr Wise Young, has announced that stem-cell therapy trials have shown very significant results in helping immobile patients to become mobile again.  Following the second round of tests that use stem cells to regrow nerve fibres, the CSCIN has applied for regulatory approval in China for a third and final phase, which…